NASDAQ
bioAffinity Technologies, Inc. (BIAF) has a eps (diluted) of $-8.66 as of Wednesday, December 31, 2025. Diluted EPS accounts for all potential shares from stock options and convertible securities, providing a more conservative earnings-per-share measure.
No price data available for this timeframe.